Related Experiment Videos
Activation of microglia: a neuroinflammatory role for CAP37
H Anne Pereira1, Xin Ruan, Padmasini Kumar
1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA. anne-pereira@ouhsc.edu
Abstract:
Recent evidence suggests that inflammation and immune function in the central nervous system (CNS) may play a considerable role in the progression of many neurodegenerative diseases. It is known that microglia, the CNS equivalent of peripheral blood monocytes, may be instrumental in causing neurotoxicity. However, the mediator(s) that activates microglia to produce toxic substances that orchestrate cell death has yet to be elucidated. We have identified a novel inflammatory molecule, cationic antimicrobial protein of molecular weight 37 kDa (CAP37), to the brains of patients dying from Alzheimer's disease. CAP37 is known to be a potent activator and regulator of monocyte function in the systemic circulation. We hypothesize that CAP37, a mediator previously shown to recruit and activate monocytes in the systemic circulation, may also play a role in CNS inflammation by modulating microglial function. Here we demonstrate that CAP37 is a chemoattractant for microglia and that CAP37-treated microglia express class II major histocompatibility antigens and produce proinflammatory cytokines and chemokines. We conclude that CAP37 has the ability to activate microglial cells and suggest that it has the potential to serve as a neuroinflammatory molecule.
Insights
Cationic antimicrobial protein of 37 kDa (CAP37) activates microglia, the immune cells of the central nervous system (CNS). This finding suggests CAP37 may be a key player in neuroinflammation and neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Neuroinflammation and microglial activation are implicated in neurodegenerative diseases.
- Microglia, the brain's immune cells, can cause neurotoxicity when activated.
- The specific mediators triggering microglial neurotoxicity remain largely unknown.
Purpose of the Study:
- To investigate the role of cationic antimicrobial protein of 37 kDa (CAP37) in central nervous system (CNS) inflammation.
- To determine if CAP37 modulates microglial function.
- To identify potential mediators of neuroinflammation in Alzheimer's disease.
Main Methods:
- Identification of CAP37 in the brains of Alzheimer's disease patients.
- Assessing CAP37's chemoattractant properties for microglia.
- Analyzing CAP37-induced changes in microglial cells, including antigen expression and cytokine/chemokine production.
Main Results:
- CAP37 was found in the brains of patients with Alzheimer's disease.
- CAP37 demonstrated chemoattractant properties for microglia.
- CAP37-treated microglia exhibited increased expression of class II major histocompatibility antigens and produced proinflammatory cytokines and chemokines.
Conclusions:
- CAP37 can activate microglial cells.
- CAP37 has the potential to act as a neuroinflammatory molecule.
- Further research into CAP37's role in neuroinflammation and neurodegenerative diseases is warranted.